col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


41 Results       Page 1

 [1] 
Bentham Science: Letters in Drug Design & Discovery
  original article Date Title Authors   All Authors
1 [GO] 2022―Oct―18 Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective Yee Choong
2 [GO] 2022―Oct―18 Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL Protease (3CL pro) Qingxiu He
3 [GO] 2022―Sep―30 Screening Active Phytochemicals of Some Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Mpro by Computational Investigation V. Alagarsamy, V. Raja Solomon, M. T. Sulthana, P. Shyam Sundar, A. Dharshini Aishwarya, B. Narendhar
4 [GO] 2022―Sep―13 Designing of a Novel Candidate Multi-Epitope Vaccine to Boost Immune Responses Against SARS-COV-2 Using Immunoinformatics and Machine Learning Based Approach Mahdi Barazesh, Shiva Mohammadi, So� Kavusi Pour, Sajad Jalili
5 [GO] 2022―Aug―19 Discovery of Potential Compounds against SARS-COV-2 Based on 3CLpro/RdRp Dual-target: An In Silico Approach Jiaojiao Li, Lin Zhu, Zheng Qin, Zhengfu Li, Xun Gao, Jing Ji, Jinyang Shen
6 [GO] 2022―Jul―04 Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses Linda Benincasa, Eleonora Molesti, Alessandro Manenti, Emanuele Montomoli, Alessio Malacrida, Valentina Zuliani, et al. (+3)
7 [GO] 2022―Jun―28 Landscape determinants of infectivity and insights into vaccine development and effectiveness - Novel Coronavirus Saba Hasan, Manish Dwivedi, Sutanu Mukhopadhyay, Nandini Gupta
8 [GO] 2022―Jun―23 Attacking the SARS-CoV-2 replication machinery with the Pathogen Box’s molecules Cleidy Osorio-Mogollón, Gustavo E. Olivos-Ramírez, Kewin Otazu, Manuel E. Chenet-Zuta, Georcki Ropón-Palacios, Cinthia das Dores Aguiar, et al. (+5)
9 [GO] 2022―Jun―21 Association of SARS-CoV-2 infection and Triple Negative Breast Cancer (TNBC)-A Computational illustrative study Hima Vyshnavi A M, P K Krishnan Namboori
10 [GO] 2022―May―31 HDAC inhibitors against SARS-CoV-2 Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
11 [GO] 2022―May―11 Bioinformatic screening of compounds from Iranian Lamiaceae family members against SARS-CoV-2 spike protein Abbas Alibakhshi, Shima Gharibi, Shahrzad Ahangarzadeh, Fatemeh Yarian
12 [GO] 2022―Apr―03 Triamcinolone as a potential inhibitor of SARS-CoV-2 main protease and cytokine storm: An in-silico study Amaresh Mishra, Faizan Abul Qais, Yamini Pathak, Ihosvany Camps, Vishwas Tripathi
13 [GO] 2022―Mar―08 Screening of Phytoconstituents from Traditional Plants against SARS-Cov2 using Molecular Docking Approach Deepika Saini, Kumud Madan, Shilpi Chauhan
14 [GO] 2022―Jan―07 Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CLpro: a study by applying Virtual Screening, Molecular Dynamics, MM-PBSA Calculations and Covalent Docking Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva-Júnior
15 [GO] 2021―Dec―30 Potential Inhibitors Identification of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Angiotensin-Converting Enzyme 2 and Main Protease from Anatolian Traditional Plants Namık Kılınç, Mikail Açar, Salih Tuncay, Ömer Faruk Karasakal
16 [GO] 2021―Oct―12 Computational Design of a Novel Candidate Multi-Epitope Vaccine to Boost Immune Responses against SARS-COV-2 Shiva Mohammadi, So� Kavusi Pour, Mahdi Barazesh, Yadollah Bahrami, Sajad Jalili
17 [GO] 2021―Oct―08 Repurposing of drugs and HTS to combat SARS-CoV-2 main protease utilizing structure-based molecular docking Sisir Nandi, Mohit Kumar, Anil Kumar Saxena
18 [GO] 2021―Oct―04 Screening and Structure-Activity Relationship of Potential Compounds against Proposed Targets of COVID-19 Infection Majid Ali, Asma Zaidi, Umar Farooq, Syed Majid Bukhari
19 [GO] 2021―Aug―05 Sequence analysis, structure prediction of receptor proteins and In silico study of potential inhibitors for management of life threatening COVID-19 Hriday K. Basak, Soumen Saha, Joydeep Ghosh, Uttam Paswan, Sujoy Karmakar, Ayon Pal, Abhik Chatterjee
20 [GO] 2021―Jun―01 Determination of binding potential of HCV protease inhibitors against SARS-CoV-2 Papain-like protease with computational docking Zihni Onur Çalışkaner
21 [GO] 2021―May―31 Virtual screening attributes male biased COVID-19 mortality to predicted antiviral activity of female sex hormones Galal Yahya, Basem Mansour, Kristina Keuper, Moataz Shaldam, Ahmed El-Baz
22 [GO] 2021―May―12 Molecular Docking Studies for Protein-Targeted Drug Development in SARS-CoV-2 Ahmad Dzulfikri Nurhan, Maria Apriliani Gani, Saipul Maulana, Siswandono Siswandono, Chrismawan Ardianto, Junaidi Khotib
23 [GO] 2021―Apr―28 Design, synthesis and in silico studies of novel N-(2-aminophenyl)-2,3-diphenylquinoxaline-6-sulfonamide derivatives targeting receptor-binding domain (RBD) of SARS-CoV-2 Spike Glycoprotein and evaluation as antimicrobial and antimalarial agents Falak A. Siddiqui, Sharuk L. Khan, Rajendra P Marathe, Nitin V. Nemac
24 [GO] 2021―Mar―19 In silico screening of phytoconstituents with antiviral activities against SARS-COV-2 main protease, Nsp12 polymerase and Nsp13 helicase proteins Jainey James, Divya Jyothi, Sneh Priya
25 [GO] 2021―Mar―03 Nanotechnology can provide therapeutic agent by targeting molecular structures of SARS-CoV-2 (COVID-19): A Mini-Review Sarwar Allah Ditta, Atif Yaqub, Fouzia Tanvir
26 [GO] 2020―Dec―26 Current scenario of COVID-19 Priyank Purohit, Ravi Kumar Mittal, Kanika Bhatt
27 [GO] 2020―Dec―26 New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments Vipan Kumar, Amruta Suryan, Jyoti Singh, Sandeep Kumar, Pradeep Kamboj, Aakash Deep
28 [GO] 2020―Dec―15 Selection of Active Antiviral Compounds Against Covid-19 Disease Targeting Coronavirus Endoribonuclease Nendou/NSP15 Via Ligand- Based Virtual Screening and Molecular Docking Gaurav Joshi, Ramarao Poduri
29 [GO] 2020―Dec―15 Design of Inhibitory Peptides of the Interaction between the RBD Domain of the S1 Protein of SARS-CoV-2 and the Angiotensin Converting Enzyme 2 (ACE2) Receptor Carlos Andrés Rodríguez-Salazar, Delia Piedad Recalde-Reyes, Jhon Carlos Castaño-Osorio
30 [GO] 2020―Dec―15 Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase Manos C. Vlasiou, Kyriakos I. Ioannou, Kyriaki S. Pafiti
31 [GO] 2020―Dec―11 In-Silico Study to Identify Dietary Molecules as Potential SARS-CoV-2 Agents Mohammad Faheem Khan, Mohsin Ali Khan, Zaw Ali Khan, Tanveer Ahamad, Waseem Ahmad Ansari
32 [GO] 2020―Nov―11 Chitosan: a promising protective component against SARS-CoV-2 and influenza virus Mohammad Reza Rahbar, Hadi Esmaeili Gouvarchin Galeh, Saeed Khalili, Abolfazl Jahangiri
33 [GO] 2020―Nov―05 Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective Yee Siew Choong, Theam Soon Lim, Hanyun Liu, Rubin Jiang, Zimu Cai, Yuan Ge
34 [GO] 2020―Oct―01 Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL protease (3CL pro) Qingxiu He, Xin Chen, Xi Yang, Guangpin Li, Haiqiong Guo, Han Chu, et al. (+2)
35 [GO] 2020―Aug―02 Preliminary Identification of Hamamelitannin and Rosmarinic Acid as COVID-19 Inhibitors Based on Molecular Docking Kaushik Sarkar, Rajesh Kumar Das
36 [GO] 2020―Aug―02 Novel Coronavirus 2019 Outbreak: A Global Epidemic Sweta Kamboj, Rohit Kamboj, Shikha Kamboj, Kumar Guarve, Rohit Dutt
37 [GO] 2020―Jul―31 Drug re-purposing from SARS-CoV led the identification of potential candidate drug target and alternate drug molecules against SARS-CoV-2 PV Parvati Sai Arun, Razak Hussain, Yusuf Akhter, Mandava Venkata Basaveswara Rao, Perugu Shyam, Sailu Yellaboina
38 [GO] 2020―Jun―13 Novel Coronavirus (COVID-19) Outbreak: Hope and Search for Effective Therapeutic Agent Saurabh Kumar
39 [GO] 2020―Apr―26 The 2019 Novel Coronavirus (COVID-19) Outbreak in China and World: A New Lesson for Public Health System Kamil Kuca
40 [GO] 2020―Apr―06 Current Strategies and Approaches in combating SARS-CoV-2 virus that causes COVID-19 D. Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela, V. Venugopal
41 [GO] 2020―Mar―17 The 2019 Novel Coronavirus (COVID-19) Outbreak in China and World: A New Lesson for Public Health System Kamil Kuca
 [1] 

41 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.023 sec